SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-22-008488
Filing Date
2022-02-18
Accepted
2022-02-18 16:31:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea155933-13da1mazur_citius.htm SC 13D/A 40488
  Complete submission text file 0001213900-22-008488.txt   41975
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Mazur Leonard L (Filed by) CIK: 0001463414 (see all company filings)

Type: SC 13D/A

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Subject) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-90253 | Film No.: 22653282
SIC: 2834 Pharmaceutical Preparations